Emricasan|254750-02-2|(恩利卡生; PF 03491390; IDN-6556)-陌孚医药/Medlife

您当前的位置：

Emricasan (Synonyms: 恩利卡生; PF 03491390; IDN-6556)

目录号: PL01465 纯度: ≥99%

CAS No. :254750-02-2

商品编号	规格	价格	会员价
PL01465-5mg	5mg	¥1360.00	请登录
PL01465-10mg	10mg	¥2225.45	请登录
PL01465-50mg	50mg	¥8654.55	请登录
PL01465-100mg	100mg	¥13600.00	请登录
PL01465-200mg	200mg	询价	询价
PL01465-500mg	500mg	询价	询价
PL01465-10mM*1mLinDMSO	10mM*1mLinDMSO	¥1703.71	请登录

Medlife所售产品仅用于科学研究（非临床研究），非药品不可食用，不可用于人体或动物的临床诊断和治疗，我们不为个人提供产品及服务。产品COA等资料，可至下方“质量控制”中下载。

加入购物车在线咨询收藏产品大包装询价

中文名称	Emricasan
中文别名	S)-3-((s)-2-(2-(2-叔丁基苯基氨基)-2-氧代乙酰氨基)丙酰胺)-4-氧代-5-(2,3,5,6-四氟苯氧基)戊酸;(S)-3-((s)-2-(2-(2-叔丁基苯基氨基)-2-氧代乙酰氨基)丙酰胺)-4-氧代-5-(2,3,5,6-四氟苯氧基)戊酸;N-[2-(叔丁基)苯基]-2-氧代甘氨酰-N-[(1S)-1-(羧基甲基)-2-氧代-3-(2,3,5,6-四氟苯氧基)丙基]-L-丙氨酰胺;恩利卡生
英文名称	Emricasan
英文别名	(S)-3-((S)-2-(2-((2-(tert-Butyl)phenyl)amino)-2-oxoacetamido)propanamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid;Emricasan;(S)-3-((S)-2-(2-((2-(tert-Butyl)phenyl)amino)-2-oxoacetamido)propanamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic...;(S)-3-((S)-2-(2-(2-TERT-BUTYLPHENYLAMINO)-2-OXOACETAMIDO)PROPANAMIDO)-4-OXO-5-(2,3,5,6-TETRAFLUOROPHENOXY)PENTANOIC ACID;(S)-3-((S)-2-(2-(2-tertbutylphenylamino)-2-oxoacetamido)propanamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid;CHEMBL197672;CS-0599;Emrian;UNII-P0GMS9N47Q;IDN-6556;N-[2-(1,1-dimethylethyl)phenyl]-2-oxoglycyl-N-[(1S)-1-(carboxymethyl)-2-oxo-3-(2,3,5,6-tetrafluorophenoxy)propyl]-L-Alaninamide;IDN 6556;N-[2-(tert-butyl)phenyl]-2-oxoglycyl-N-[(1S)-1-(carboxymethyl)-2-oxo-3-(2,3,5,6-tetrafluorophenoxy)propyl]-L-alaninamide;Emricasan(IDN6556,PF03491390);PF 03491390;P0GMS9N47Q;Emricasan [USAN:INN];Emricasan (USAN/INN);GTPL6508;C26H27F4N3O7;BCP07463;s7775;2073AB
Cas No.	254750-02-2
分子式	C₂₆H₂₇F₄N₃O₇
分子量	569.50
包装储存	Powder -20°C 3 years；4°C 2 years

产品详情

Emricasan (PF 03491390) 是一种口服有效的不可逆 pan-caspase 抑制剂。Emricasan 抑制 Zika 病毒 (ZIKV) 诱导的 caspase-3 活性增加并保护了人类皮层神经祖细胞。

生物活性

Emricasan (PF 03491390) is an orally active and irreversible pan-caspase inhibitor. Emricasan inhibits Zika virus (ZIKV)-induced increases in caspase-3 activity and protected human cortical neural progenitors.

性状

Solid

IC50 & Target[1][2]

Caspase

体外研究(In Vitro)

Emricasan (PF 03491390; IDN-6556) (50 μM; 24 hours) directly improves hepatocytes phenotype in primary rat cirrhotic hepatocytes.
Emricasan (10-50 μM) has hepatoprotective effects in human liver cells.
has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究(In Vivo)

Emricasan (PF 03491390; IDN-6556) is orally active that is retained in the liver for prolonged period of time. TUNEL-positive cells are considerably increased by five-fold in mice fed a HFD and are reduced under Emricasan treatment. In accordance with this observation caspase-3 and -8 are increased in HFD-fed mice by 1.5- and 1.3-fold respectively and are significantly decreased by Emricasan treatment.
When comparing efficacy by multiple routes of administration, Emricasan is administered i.p., p.o., i.m., or i.v. (0.03-3 mg/kg). Caspase 3-like activities, measured as DEVD-AMC cleavage, dose dependently decreased with a 92.5% reduction after the highest dose of Emricasan (3 mg/kg). Emricasan is initially tested in the α-Fas model of liver injury, marked hepatocellular apoptosis, and peak ALT activities within 6 h. Emricasan is administered i.p. immediately after administr

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Powder -20°C 3 years；4°C 2 years

ClinicalTrial

参考文献

[1]. Gracia-Sancho J, et al. Emricasan Ameliorates Portal Hypertension and Liver Fibrosis in Cirrhotic Rats Through a Hepatocyte-Mediated Paracrine Mechanism. Hepatol Commun. 2019 Apr 22;3(7):987-1000.
[2]. Barreyro FJ, et al. The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis. Liver Int. 2015 Mar;35(3):953-66.

溶解度数据	In Vitro: DMSO : 100 mg/mL (175.59 mM; Need ultrasonic)配制储备液

搜索质检报告(COA)

产品使用指南

Data Sheet

1：一般建议：溶解度为Medlife测试数据，可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解，请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异，仅做参考，具体以实验方案为准。

2：储存条件：粉末-20°C一般情况可以保存3年，溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异，请细致阅读产品信息，并辅助参考相关文献描述。

相关产品

The molarity calculator equation

The dilution calculator equation